Safety study of GR2301 injection in healthy volunteers
Treatments studied
This trial tests a new injection called GR2301 to see if it is safe in healthy people. Volunteers will help researchers understand any side effects before the drug is given to patients with a disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult
- Your body mass index (BMI) must be between 19.0 and 28.0
- Men must weigh at least 110 lbs (50 kg); women at least 99 lbs (45 kg)
- You cannot have any ongoing or past medical conditions that might affect the trial
- You cannot use drugs or have a history of substance abuse
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early Phase 1 trial testing a new investigational drug called CM326 given as an injection. The study measures how your body absorbs, distributes, and eliminates the drug. Researchers are enrolling only healthy volunteers to understand the drug's basic safety and how it moves through the body.
This is an early-stage study testing a new medicine called GR2301 given as multiple injections. Researchers want to see how safe it is and how the body handles it in healthy volunteers with no serious medical conditions.
This trial tests a new drug called GR2303 to see if it is safe and how the body processes it. It is for healthy adults who have not used similar drugs before.
This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This study tests a new injection called LX22001 in healthy volunteers to see how it is processed in the body and if it is safe. It is a first-in-human trial, so you must be in good health and meet specific age, weight, and lifestyle requirements.
Hear when a new Single Ascending Dose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.